Comprehensive Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Evaluation of Once-Daily Efavirenz 400 and 600 mg in Treatment-Naive HIV-Infected Patients at 96 Weeks: Results of the ENCORE1 Study



Dickinson, Laura, Amin, Janaki, Else, Laura, Boffito, Marta, Egan, Deirdre, Owen, Andrew ORCID: 0000-0002-9819-7651, Khoo, Saye, Back, David, Orrell, Catherine, Clarke, Amanda
et al (show 6 more authors) (2016) Comprehensive Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Evaluation of Once-Daily Efavirenz 400 and 600 mg in Treatment-Naive HIV-Infected Patients at 96 Weeks: Results of the ENCORE1 Study. CLINICAL PHARMACOKINETICS, 55 (7). 861 - 873.

[img] Text
Dickinson_E1_96wk_CPK_revision1_clean.docx - Accepted Version

Download (186kB)
Item Type: Article
Depositing User: Symplectic Admin
Date Deposited: 13 Jul 2018 15:06
Last Modified: 12 Nov 2019 13:59
DOI: 10.1007/s40262-015-0360-5
Related URLs:
URI: http://livrepository.liverpool.ac.uk/id/eprint/3002215
Repository Staff Access